Patents by Inventor Debra Mazaik

Debra Mazaik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SALT AND CRYSTAL FORMS OF AN ACTIVIN RECEPTOR-LIKE KINASE INHIBITOR
    Publication number: 20220281879
    Abstract: Various salt forms of Compound (I) represented by the following structural formula, and their corresponding pharmaceutical compositions, are disclosed. Particular single crystalline forms of 1:1.5 Compound (I) succinate, 1:1 Compound (I) hydrochloride salt, and 1:1 Compound (I) fumarate salt are characterized by a variety of properties and physical measurements. Methods of preparing specific crystalline forms are also disclosed. The present disclosure also provides methods of treating or ameliorating fibrodysplasia ossificans progressive in a subject.
    Type: Application
    Filed: August 12, 2020
    Publication date: September 8, 2022
    Inventors: Clare Medendorp, Debra Mazaik, Gordon Wilkie, Joshua D. Waetzig, Brian Heinrich, Lauren MacEachern, Dominik Siegel, Harald Ohmer, Steven C. Johnston
  • Crystalline form of a proteasome inhibitor
    Patent number: 10072029
    Abstract: The present disclosure relates to a novel crystalline form of a proteasome inhibitor, and to the processes for the preparation thereof. The novel crystalline form according to the disclosure may be used in the preparation of pharmaceutical compositions for the treatment of cancer.
    Type: Grant
    Filed: February 10, 2016
    Date of Patent: September 11, 2018
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Marianne Langston, Debra Mazaik, Eric Elliott, Anton Peterson, Patricia Andres, Jing Teng
  • NOVEL CRYSTALLINE FORM OF A PROTEASOME INHIBITOR
    Publication number: 20180044356
    Abstract: The present disclosure relates to a novel crystalline form of a proteasome inhibitor, and to the processes for the preparation thereof. The novel crystalline form according to the disclosure may be used in the preparation of pharmaceutical compositions for the treatment of cancer.
    Type: Application
    Filed: February 10, 2016
    Publication date: February 15, 2018
    Inventors: Marianne Langston, Debra Mazaik, Eric Elliott, Anton Peterson, Patricia Andres, Jing Teng